Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.54 USD | +12.89% | +20.67% | +3.25% |
03-27 | HC Wainwright Adjusts BioAtla's Price Target to $7 From $10, Maintains Buy Rating | MT |
03-26 | Transcript : BioAtla, Inc., Q4 2023 Earnings Call, Mar 26, 2024 |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 122M 9.78B |
---|---|---|---|---|---|
Net income 2024 * | -107M -8.57B | Net income 2025 * | -127M -10.17B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.31
x | P/E ratio 2025 * |
-1.44
x | Employees | 65 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.17% |
Latest transcript on BioAtla, Inc.
1 day | +12.89% | ||
1 week | +20.67% | ||
Current month | -26.16% | ||
1 month | -15.61% | ||
3 months | +23.30% | ||
6 months | +90.98% | ||
Current year | +3.25% |
Managers | Title | Age | Since |
---|---|---|---|
Jay Short
CEO | Chief Executive Officer | 66 | 28/02/07 |
Founder | 59 | 28/02/07 | |
Richard Waldron
DFI | Director of Finance/CFO | 70 | 31/12/10 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mary Gray
BRD | Director/Board Member | 71 | 30/11/20 |
Jay Short
CEO | Chief Executive Officer | 66 | 28/02/07 |
Director/Board Member | 76 | 31/12/15 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.03% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.01% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 2.54 | +12.89% | 295,270 |
25/04/24 | 2.25 | -4.26% | 398,980 |
24/04/24 | 2.35 | +4.91% | 395,798 |
23/04/24 | 2.24 | +2.75% | 672,657 |
22/04/24 | 2.18 | +3.56% | 872,008 |
Delayed Quote Nasdaq, April 26, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.25% | 122M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- BCAB Stock